The 'omics' revolution offers a gateway to a new level of precision medicine in chronic liver disease. In this session, we highlight six outstanding examples of genomic and metabolic exporations into pathogenesis and diagnosis of HCC on the one hand, and MASLD on the other.
Objectives
Learn about genomic advances into understanding mechanisms of hepatocarinogenesis
Identify novel targets for future therapeutic interventions in hepato-biliary cancers.
Recognize new metabolic pathways involved in MASLD.